Guy C. Jackson
CIK 1248950 · last filed 2015-11-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.15M
Companies
5
Total Filings
48
Lifetime Open-Market Net
-$2.21M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DGII | Director | 44,707 | $70.55 | $3.15M | -$310.4K | 14 | 2015-11-25 |
| CYBERONICS INC (CYBX) Delisted | Director | 0 | — | — | -$1.78M | 16 | 2015-10-19 |
| LTM | Director | 0 | $58.73 | $0 | -$117.8K | 10 | 2015-06-11 |
| IMMUNE PHARMACEUTICALS INC (EPCT) Delisted | Director | — | — | — | $0 | 5 | 2010-06-07 |
| UROLOGIX INC (ULGX) Delisted | Director | 16,774 | — | — | $0 | 3 | 2009-11-12 |
Recent Filings · Page 4 of 5
48 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-04-29 | LTM | Grant (A) | +2,067 | $0 | EDGAR |
| 2010-01-28 | DGII | Grant (A) | — | $0 | EDGAR |
| 2009-11-12 | UROLOGIX INC (ULGX) Delisted | Grant (A) | +8,774 | $0 | EDGAR |
| 2009-06-10 | CYBERONICS INC (CYBX) Delisted | Grant (A) | +5,095 | $0 | EDGAR |
| 2009-06-04 | IMMUNE PHARMACEUTICALS INC (EPCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-04-30 | LTM | Grant (A) | +4,576 | $0 | EDGAR |
| 2009-01-29 | DGII | Grant (A) | — | $0 | EDGAR |
| 2008-11-13 | UROLOGIX INC (ULGX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-07-02 | IMMUNE PHARMACEUTICALS INC (EPCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-06-18 | CYBERONICS INC (CYBX) Delisted | Grant (A) | +3,582 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.